Filing Details

Accession Number:
0001209191-13-045144
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-09-20 18:03:12
Reporting Period:
2013-09-18
Filing Date:
2013-09-20
Accepted Time:
2013-09-20 18:03:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1368148 Athersys Inc / New ATHX Pharmaceutical Preparations (2834) 204864095
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1402610 J John Harrington 3201 Carnegie Avenue
Cleveland OH 44115
Chief Scientific Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-09-18 15,619 $1.78 651,576 No 4 F Direct
Common Stock Disposition 2013-09-20 30,000 $1.82 621,576 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
Footnotes
  1. Shares withheld from the quarterly vesting of a June 2013 restricted stock unit award to partially satisfy the related tax obligation.
  2. Shares sold for tax and planning purposes related to the quarterly vesting of a June 2013 restricted stock unit award.
  3. Securities beneficially owned are comprised of: (1) 98,571 shares of common stock owned, and (2) 523,005 restricted stock units, awarded on June 20, 2013, related to the termination of 2005 incentive agreements and that will vest ratably, on a quarterly basis through June 18, 2016.